Effect of a herbal extract containing curcumin and piperine on midazolam, flurbiprofen and paracetamol (acetaminophen) pharmacokinetics in healthy volunteers (2013)

Peer-Reviewed Study · Volak LP, Hanley MJ, Masse G, Hazarika S, Harmatz JS, Badmaev V, Majeed M, Greenblatt DJ, Court MH · February 2013

Volak LP et al., 2013-02: Randomised placebo-controlled six-way crossover study in eight healthy volunteers: 4 g curcuminoids with 24 mg piperine did not change the pharmacokinetics of midazolam (CYP3A), flurbiprofen (CYP2C9) or paracetamol (UGT/SULT).

the curcuminoid/piperine treatment produced no meaningful changes in plasma C(max), AUC, clearance, elimination half-life or metabolite levels of midazolam, flurbiprofen or paracetamol

Abstract, Results

Volak LP et al., 2013-02: Randomised placebo-controlled six-way crossover study in eight healthy volunteers: 4 g curcuminoids with 24 mg piperine did not change the pharmacokinetics of midazolam (CYP3A), flurbiprofen (CYP2C9) or paracetamol (UGT/SULT). Tests the CYP3A4 inhibition claim the book's caution rests on, at a high oral dose, and finds no clinically meaningful interaction; unconjugated curcumin was below assay threshold. Comparator: placebo pre-treatment. Funder and disclosures not carried in the PubMed record. Study type: randomized trial.